Surfers Roger Green, Jörn Schattenberg and Louise Campbell embark on their first exclusive discussion together in a while without any guest panelists. After several weeks of attending and reviewing conferences, the trio take the opportunity to talk about what the next year holds for the NAFLD-metabolic disease link.
Program speakers Mazen Noureddin, Sven Francque and Hannes Hagström join Roger Green, on-site from Dublin to review their thoughts and key takeaways immediately after the NAFLD Summit ended. In this final conversation, the group discusses NITs and what will change between now and when this conference convenes next year.
Program speakers Mazen Noureddin, Sven Francque and Hannes Hagström join Surfer, Roger Green, on-site from Dublin to review their thoughts and key takeaways immediately after the NAFLD Summit ended. In this conversation, the group explores issues around clinical trial design, focusing specifically on the value of Phases 2a and 2b and whether improvement in patient self-management during trials is a research artifact or a replication of reality.
The 2022 NAFLD Summit proved to be an in-depth, successful conference brought to life by key opinion leaders in fatty liver and metabolic disease from around the world. In Season 3, Episode 46, Surfer Roger Green hosts a review on site in Dublin with presenting speakers Mazen Noureddin, Sven Francque and Hannes Hagström.
In this conversation From Inside the Vault, NAIL-NIT co-leads Stephen Harrison and Mazen Noureddin and retrospective analysis co-leads Naim Alkhouri and Jörn Schattenberg join Louise Campbell and Roger Green to discuss designs and plans for NAIL-NIT retrospective analysis.
In a review of Paris NASH 2022, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by patient advocate, Jeff McIntyre. In this final conversation, the group explores the rest of the Day Two program, focusing on the development of an NIT diagnostic pathway. Finally, each offers their closing remarks on being a part of the 8th Paris NASH Meeting and what the future looks like in this space.
In a review of Paris NASH 2022, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by patient advocate, Jeff McIntyre. In this conversation, the group discusses presentations on adaptive trial strategies, trial recruitment and reducing screen fail rates, and the impact of educating patients on better self-care.
In a review of Paris NASH 2022, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by patient advocate, Jeff McIntyre. In this conversation, the group shares one particularly striking takeaway from the meeting.
In this episode From the Vault, Jörn Schattenberg, Stephen Harrison and Roger Green review some highlights from the 2021 Paris NASH Meeting. This conversation looks at the Day Two sessions and the overall implications of the meeting.
In Part 2 of Season 3, Episode 44, host Roger Green kicks off a series of 1 on 1 interviews with friend of the podcast, Dr. Jeffrey Lazarus. In this conversation, the two discuss a preview of NAFLD Summit 2022 in Dublin, 15-17 September.
Hepatologist Naim Alkhouri and Endocrinologist Scott Isaacs join Ken Cusi and Roger Green to discuss drug choices prescribers can make
